Synapse - Fiona Murray

Fiona Murray

Research Focus

Nursing; Clinical Nurse II

Recent additions – View all

Oral proteasome inhibitor ixazomib for switch-maintenance prophylaxis of recurrent or late acute and chronic graft-versus-host disease after day 100 in allogeneic stem cell transplantation
Journal Article

Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S. M.; Soto, C.; Cho, C.; Dahi, P.; Giralt, S.; Perales, M. A.; more...
Transplantation and Cellular Therapy (2021)

Fulltext@MSK | Save
Secondary graft-versus-host disease (GVHD) prophylaxis with oral proteasome inhibitor ixazomib is associated with low incidence of recurrent, late acute and chronic GVHD and facilitated calcineurin inhibitor taper within the first year post allogeneic stem cell transplantation
Meeting Abstract

Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S.; Izquierdo, C. S.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Sauter, C. S.; more...
Blood (2020)

Fulltext@MSK | Save

Co-authors at MSK

2

Cho
2

Dahi
2

Devlin
2

Flynn
2

Giralt
2

Lee
2

Perales
2

Ponce
2

Rodriguez
2

Sauter
2

Soto Iz...

Types of Work

Publications

Blood (1)
Transplantation and Cellular Therapy (1)